3rd Quarter - Report — THE MCMANUS GROUP for ACHAOGEN (2018)

Firm

THE MCMANUS GROUP

Client

ACHAOGEN

Income

$30,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement; development of policies to advance the antimicrobial research and development environment. Support for H.R. 6294 - REVAMP Act.

Lobbyist	Covered position, as disclosed
PAUL BRYAN CRONAN New	—
JOHN MCMANUS	—
BARRETT THORNHILL	—

Contacted: Office of Management & Budget (OMB); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6294 (115th)

Medicare/Medicaid MMM

Medicare payment for inpatient antibiotics.

Lobbyist	Covered position, as disclosed
PAUL BRYAN CRONAN	—
JOHN MCMANUS	—
BARRETT THORNHILL	—

Contacted: Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.